EPIKAST
LIVE

Serial Number

99298653

Owner

Epikast, Inc.

Attorney

Betsy Wang Lee

Filing Date

Jul 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EPIKAST Trademark

Serial Number: 99298653

EPIKAST is a trademark filed by Epikast, Inc. on July 23, 2025. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Epikast, Inc.

180 Varick Street, 6th Floor,
New York, NY 10014

Entity Type: 99

Trademark Details

Filing Date

July 23, 2025

Registration Date

Not Registered

Goods & Services

Business organization consulting in the pharmaceutical, biotechnology and life sciences fields; advertising and marketing in the pharmaceutical, biotechnology and life sciences fields; analyzing and compiling business data in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; promoting the exchange of health information within the medical community to achieve advances in the field of healthcare and promote patient adherence.

Providing medical information to physicians and health care professionals; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notification

Medical, scientific and data analysis research services, namely, analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development and clinical research services, consulting services in the area of pharmaceutical clinical testing, namely, artificial intelligence (AI) powered data management of clinical trials, biostatistical analysis, preclinical research and development evaluation; providing life science and scientific research information to healthcare professionals, patients, and medical, pharmaceutical and biotechnology companies, using artificial intelligence (AI) models that provide insights from transcripts and artificial intelligence (AI) models that summarize the latest medical knowledge in a particular field; Internet development, design and consulting services, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the sharing of medical and pharmaceutical information.

Educational services, namely, providing non-downloadable webinars and live workshops in the field of pharmaceutical sales; providing on-line non-downloadable videos in the field of pharmaceutical sales; providing on-line non-downloadable publications in the nature of articles and white papers in the field of pharmaceutical sales; providing podcasts in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields via email; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts educational services, namely, providing non-downloadable webinars and live workshops in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing on-line non-downloadable publications in the nature of articles and white papers in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing podcasts in the field of clinical trials.

Filing History

WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Feb 24, 2026 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2026 CNEA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 16, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2026 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 23, 2025 MAFR
NEW APPLICATION ENTERED
Jul 23, 2025 NWAP